Phenobarbitone (the active ingredient)Inactive ingredients (vary by formulation – check product labeling for specifics)
Treatment of seizures (epilepsy)
Shortterm management of anxiety (rarely used for this now due to safety concerns)
Treatment of certain types of status epilepticus (severe, prolonged seizure)
Preoperative sedation (less common due to newer safer options)
Shinosun 30mg Tablet (Phenobarbitone) is a barbiturate that enhances the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system. This leads to decreased neuronal excitability and reduces the likelihood of seizures.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Discard any unused medication according to instructions.
Dosage is determined by the physician based on individual needs and condition. It should never be altered without medical supervision.
The medication can be taken orally (tablets or capsules) or intravenously (in a hospital setting).
Never crush or break extended-release tablets unless instructed to do so by a doctor.
Drowsiness
Dizziness
Confusion
Unsteady gait
Depression
Skin rashes
Liver damage (rare but serious)
Respiratory depression (in overdose)
Should be strictly avoided as it can increase the risk of drowsiness and other adverse effects.
Avoid driving or operating machinery until you know how phenobarbitone affects you. Drowsiness is a common side effect.
Use during pregnancy and breastfeeding should only be considered if the potential benefits outweigh the risks. Discuss with your doctor.
Dosage must be carefully adjusted based on weight and age. Must be administered under strict medical supervision.
Reduced kidney function may require dose adjustment to avoid accumulation and toxicity.
Liver function should be monitored, especially during long-term use, due to the potential for liver damage.
Your doctor or pharmacist
Your medication's package insert
Reputable medical websites (e.g., Mayo Clinic, NHS)
